SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 15.53% in the revenue at Rs. 4612.40 millions was reported in the March 2025 quarter as compared to Rs. 3992.40 millions during year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 512.20 millions grew from Rs.-1149.70 millionsThe company reported a good operating profit of 810.30 millions compared to 376.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4612.40 3992.40 15.53 17357.00 14421.60 20.35 17357.00 14421.60 20.35
Other Income 60.50 70.40 -14.06 408.30 303.90 34.35 408.30 303.90 34.35
PBIDT 810.30 376.30 115.33 2947.10 813.00 262.50 2947.10 813.00 262.50
Interest 15.30 17.60 -13.07 76.20 104.20 -26.87 76.20 104.20 -26.87
PBDT 835.00 -897.50 -193.04 2910.90 132.70 2093.59 2910.90 132.70 2093.59
Depreciation 274.70 252.20 8.92 1084.10 1054.50 2.81 1084.10 1054.50 2.81
PBT 560.30 -1149.70 -148.73 1826.80 -921.80 -298.18 1826.80 -921.80 -298.18
TAX 48.10 0.00 0.00 197.20 0.00 0.00 197.20 0.00 0.00
Deferred Tax 48.10 0.00 0.00 197.20 0.00 0.00 197.20 0.00 0.00
PAT 512.20 -1149.70 -144.55 1629.60 -921.80 -276.78 1629.60 -921.80 -276.78
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 17.57 9.43 86.39 16.98 5.64 201.19 16.98 5.64 201.19

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×